Literature DB >> 34697770

Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases.

Akshay Bandiwadekar1, Jobin Jose2, Maryam Khayatkashani3, Solomon Habtemariam4, Hamid Reza Khayat Kashani5, Seyed Mohammad Nabavi6.   

Abstract

Neurodegenerative diseases (NDs) such as Alzheimer's disease, Parkinson's disease, Huntington disease, amyotrophic lateral sclerosis, and prion disease affect any part of the brain. The complete mechanism of ND is unknown, but there are some molecular mechanism and chemical process. Natural compounds have better compatibility with the human body along with lesser side effects. Moreover, several studies showed that various natural compounds have significant neuroprotective, potent antioxidant, and anti-inflammatory properties, which are effective for treating the different type of ND. In ND, natural compounds act by various mechanisms such as preventing the generation of reactive oxygen species (ROS), eliminating destructed biomolecules before their accumulation affects cell metabolism, and improving the disease conditions. But due to the presence of the blood-brain barrier (BBB) layer and unfavorable pharmacokinetic properties of natural compounds, their delivery into the brain is limited. To minimize this problem and enhance drug delivery into the brain with an effective therapeutic dose, there is a need to develop a practical novel approach. The various studies showed that nanoformulations and microneedles (MN) containing natural compounds such as quercetin, curcumin, resveratrol, chrysin, piperine, ferulic acid, huperzine A, berberine, baicalein, hesperetin, and retinoic acid effectively improved many ND. In this review, the effect of such natural drug-loaded nanoformulation and MN patches on ND management is discussed, along with their merits and demerits. This review aims to introduce different novel approaches for enhancing natural drug delivery into the brain to manage various neurodegenerative diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Microneedles; Nanoparticle; Natural products; Neurodegenerative diseases

Mesh:

Substances:

Year:  2021        PMID: 34697770     DOI: 10.1007/s12031-021-01922-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  113 in total

Review 1.  PLGA-based nanoparticles: an overview of biomedical applications.

Authors:  Fabienne Danhier; Eduardo Ansorena; Joana M Silva; Régis Coco; Aude Le Breton; Véronique Préat
Journal:  J Control Release       Date:  2012-02-04       Impact factor: 9.776

2.  Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Ghulam M Ashraf; Nigel H Greig; Taqi A Khan; Iftekhar Hassan; Shams Tabrez; Shazi Shakil; Ishfaq A Sheikh; Syed K Zaidi; Mohammad Akram; Nasimudeen R Jabir; Chelaprom K Firoz; Aabgeena Naeem; Ibrahim M Alhazza; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

3.  Transdermal delivery of dimethyl fumarate for Alzheimer's disease: Effect of penetration enhancers.

Authors:  Dina Ameen; Bozena Michniak-Kohn
Journal:  Int J Pharm       Date:  2017-07-12       Impact factor: 5.875

Review 4.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

Review 5.  Improving drug delivery technology for treating neurodegenerative diseases.

Authors:  Yahya E Choonara; Pradeep Kumar; Girish Modi; Viness Pillay
Journal:  Expert Opin Drug Deliv       Date:  2016-03-24       Impact factor: 6.648

Review 6.  Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems.

Authors:  Eleni Bagli; Anna Goussia; Marilita M Moschos; Niki Agnantis; Georgios Kitsos
Journal:  In Vivo       Date:  2016 09-10       Impact factor: 2.155

7.  Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.

Authors:  Preetha Anand; Hareesh B Nair; Bokyung Sung; Ajaikumar B Kunnumakkara; Vivek R Yadav; Rajeshwar R Tekmal; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2009-09-06       Impact factor: 5.858

Review 8.  Oxidative stress in the pathogenesis of diffuse lung diseases: a review.

Authors:  E Bargagli; C Olivieri; D Bennett; A Prasse; J Muller-Quernheim; P Rottoli
Journal:  Respir Med       Date:  2009-05-22       Impact factor: 3.415

9.  Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity.

Authors:  V Satish Bollimpelli; Prashant Kumar; Sonali Kumari; Anand K Kondapi
Journal:  Neurochem Int       Date:  2016-01-28       Impact factor: 3.921

10.  Evaluation of the clinical impact of repeat application of hydrogel-forming microneedle array patches.

Authors:  Rehan Al-Kasasbeh; Aaron J Brady; Aaron J Courtenay; Eneko Larrañeta; Maelíosa T C McCrudden; Donal O'Kane; Stephen Liggett; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2020-06       Impact factor: 4.617

View more
  7 in total

Review 1.  Stem Cells and Natural Agents in the Management of Neurodegenerative Diseases: A New Approach.

Authors:  Aranka Brockmueller; Negin Mahmoudi; Amir Kian Movaeni; Anna-Lena Mueller; Abdol-Mohammad Kajbafzadeh; Mehdi Shakibaei; Masoumeh Majidi Zolbin
Journal:  Neurochem Res       Date:  2022-09-16       Impact factor: 4.414

2.  Hesperetin, a Citrus Flavonoid, Ameliorates Inflammatory Cytokine-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation.

Authors:  Satoshi Nishino; Yoko Fujiki; Takanari Sato; Yukino Kato; Remina Shirai; Hiroaki Oizumi; Masahiro Yamamoto; Katsuya Ohbuchi; Yuki Miyamoto; Kazushige Mizoguchi; Junji Yamauchi
Journal:  Neurol Int       Date:  2022-05-31

Review 3.  Elucidating the Beneficial Effects of Ginger (Zingiber officinale Roscoe) in Parkinson's Disease.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Sokratis G Papageorgiou; Christina Piperi
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-07

Review 4.  Berberine: A Promising Treatment for Neurodegenerative Diseases.

Authors:  Ziqian Cheng; Chenglan Kang; Songtian Che; Jingyun Su; Qihan Sun; Tongtong Ge; Yi Guo; Jiayin Lv; Zhihui Sun; Wei Yang; Bingjin Li; Xin Li; Ranji Cui
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

Review 5.  Oxidative Stress in the Pathogenesis of Aorta Diseases as a Source of Potential Biomarkers and Therapeutic Targets, with a Particular Focus on Ascending Aorta Aneurysms.

Authors:  Calogera Pisano; Umberto Benedetto; Giovanni Ruvolo; Carmela Rita Balistreri
Journal:  Antioxidants (Basel)       Date:  2022-01-18

6.  Protective Effect of Resveratrol against Hypoxia-Induced Neural Oxidative Stress.

Authors:  Amogh Auti; Nicola Alessio; Andrea Ballini; Mario Dioguardi; Stefania Cantore; Salvatore Scacco; Antonio Vitiello; Lucio Quagliuolo; Barbara Rinaldi; Luigi Santacroce; Marina Di Domenico; Mariarosaria Boccellino
Journal:  J Pers Med       Date:  2022-07-23

7.  Development of Microneedle Patch Loaded with Bacopa monnieri Solid Lipid Nanoparticles for the Effective Management of Parkinson's Disease.

Authors:  Delna Joy; Jobin Jose; Shabana Bibi; Akshay Bandiwadekar; Gopika Gopan; Clara Mariana Gonçalves Lima; Talha Bin Emran; Fahad A Alhumaydhi; Harsha Ashtekar; Sandeep D S; Carlos Adam Conte-Junior
Journal:  Bioinorg Chem Appl       Date:  2022-08-10       Impact factor: 4.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.